Moderna Posts Q4 Loss of $826M, Revenue $678M; EPS -$2.11 (MRNA)

Moderna Inc. (MRNA) reported a fourth-quarter loss of $826 million, or $2.11 per share, on Friday. Revenue for the quarter totaled $678 million, exceeding the $659.5 million average estimate. The results surpassed analyst expectations, with the average loss forecast of $2.60 per share. For the year, the company recorded a loss of $2.82 billion, or $7.26 per share, and revenue of $1.94 billion.